Group 1 - The Ministry of Industry and Information Technology (MIIT) has announced the first batch of 43 biomanufacturing pilot capacity building platforms, selected through recommendations from provincial authorities, expert evaluations, and public announcements [1] - Notable companies included in the list are Shandong Qilu Pharmaceutical Co., Ltd. (biopharmaceuticals), Shandong Longkete Enzyme Preparations Co., Ltd. (enzyme preparations), and Shandong University (food and additives, enzyme preparations) [1] - The MIIT aims to promote collaborative innovation across the industry chain by focusing on key product areas such as food and additives, biopharmaceuticals, cosmetics, chemicals, energy, and enzyme preparations [1] Group 2 - Platforms listed must concentrate on their respective service areas, increase resource investment, enhance hardware and software infrastructure, and improve professional talent training [1] - The MIIT will conduct annual evaluations of the platforms based on their hardware and software levels, the quantity and quality of pilot services provided, and will dynamically adjust the service capability ratings [1] - Platforms that fail to meet service capability and effectiveness requirements, or violate regulations related to intellectual property, safety production, environmental protection, and quality safety, will be removed from the list [1]

Core Insights - The biomanufacturing industry in China is steadily expanding, with a total scale reaching 1.1 trillion yuan, and bioproducts accounting for over 70% of global production [1] - Key segments such as food additives and biopharmaceuticals have an annual output value exceeding 400 billion yuan, positioning biomanufacturing as a new economic growth driver [1] Technological Innovation - Significant achievements in technological innovation have been noted, with China's patent applications in the biomanufacturing sector accounting for over 20% of the global total [1] - A number of national key laboratories and industrial innovation platforms have been established, enhancing innovation capabilities [1] Industry Structure and Clusters - The advantages of industrial clusters are becoming more pronounced, with regions like Beijing and Tianjin emerging as innovation hubs, while Shandong, Heilongjiang, and Henan are developing into major manufacturing bases for bulk bioproducts [1] - Original achievements are continuously emerging from areas like Chongqing and Guangdong [1] Market Development - During the 14th Five-Year Plan period, several backbone enterprises with annual revenues exceeding 10 billion yuan have been cultivated in the biomanufacturing sector [1] - The establishment of dozens of national-level manufacturing champions and specialized "little giant" enterprises has been reported, along with the development of over 40 pilot capacity-building platforms and quality incubators [1]

Core Viewpoint - The Ministry of Industry and Information Technology and the National Development and Reform Commission have issued a notice to cultivate pilot-scale biomanufacturing platforms, aiming to establish over 20 platforms and serve more than 200 enterprises by 2027, with the goal of incubating over 400 products [1][2][3]. Group 1: Cultivation Areas - The initiative focuses on addressing the shortcomings and pain points in the pilot-scale phase of biomanufacturing, targeting key product areas such as food and additives, biopharmaceuticals, cosmetics, chemicals, energy, and enzyme preparations [5]. - Emphasis will be placed on developing pilot platforms for new raw materials in biomanufacturing, particularly lignocellulosic materials and one-carbon compounds (e.g., carbon monoxide, methanol) [5]. - The program will also support the establishment of pilot platforms for plant chassis cells, which utilize genetically modified plant cells (such as tobacco, rice, and Taxus cells) to fill gaps in emerging fields [5].

Core Viewpoint - The article discusses the establishment of pilot testing platforms for biomanufacturing, focusing on key product areas such as food additives, biopharmaceuticals, cosmetics, chemicals, energy, and enzyme preparations, with a goal to support innovation and commercialization in the industry [1][2]. Group 1: Pilot Testing Platforms - The Ministry of Industry and Information Technology and the National Development and Reform Commission aim to cultivate over 20 pilot testing platforms by 2027, serving more than 200 enterprises and incubating over 400 products [1]. - The initiative emphasizes market-driven and demand-led approaches, encouraging national laboratories and innovation platforms to develop pilot testing capabilities [1][2]. - The platforms will focus on addressing the shortcomings and pain points in the pilot testing phase of biomanufacturing, particularly in the development of new raw materials such as lignocellulosic and one-carbon compounds [2]. Group 2: Guidelines and Events - The article includes attachments such as the "Biomanufacturing Pilot Testing Capability Construction Platform Cultivation Guidelines (2025 Edition)" and an application form for the platform [3]. - The Fourth Synthetic Biology and Green Biomanufacturing Conference (SynBioCon 2025) is scheduled for August 20-22 in Jinan, Shandong, aiming to discuss trends in biomanufacturing and promote technology transfer and commercialization [4].

Core Viewpoint - The Ministry of Industry and Information Technology and the National Development and Reform Commission have initiated a program to cultivate pilot-scale biomanufacturing capabilities, focusing on addressing gaps and pain points in the biomanufacturing sector [1] Group 1: Biomanufacturing Focus Areas - The initiative aims to develop pilot platforms for key product areas including food and additives, biopharmaceuticals, cosmetics, chemicals, energy, and enzyme preparations, promoting collaborative innovation across the industry chain [1] - Emphasis is placed on cultivating pilot platforms for new raw material development, particularly in lignocellulosic materials and one-carbon compounds (such as carbon monoxide and methanol) [1] - The program will also focus on establishing pilot platforms for plant chassis cells, which utilize genetically modified plant cells (such as tobacco, rice, and Taxus cells) to address emerging field gaps in biomanufacturing [1]